ORGN 117 |
| Arylglycines are components of a number of significant drugs, such as Plavix, one of the top grossing pharmaceuticals for 2005. As a result, the asymmetric synthesis of these compounds is an important goal in organic chemistry. Recently, much attention has been focused on metal-catalyzed additions of arylboronic acids to N-protected aryl or alkyl imines. Herein we report an efficient asymmetric synthesis of arylglycines based on a rhodium-catalyzed addition of arylboronic acids to N-sulfinyl iminoacetates. This method proceeds with high yields and high diastereoselectivities for a variety of electronically diverse substituted arylboronic acid derivatives. We have also demonstrated the utility of the subsequent protected arylglycine products by subjecting them to further synthetic transformations, including peptide coupling. |
|
Asymmetric Reactions and Syntheses, Metal-Mediated Reactions, Combinatorial, Parallel, and Solid-Phase Chemistry
8:00 PM-10:00 PM, Sunday, 10 September 2006 Moscone Center -- Hall D, Poster
Sci-Mix
Division of Organic Chemistry |